Form 4 Tracker
ARS Pharmaceuticals, Inc.
SPRY

11 insider filings · Latest: Jun 24, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 21, 2024Aug 21 10:43 PMOrbiMed Partners Master Fund Limited
Proposed Sale
952,377$14.89$14.2M

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 24, 2026Jun 26 8:52 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Grant/Award
30,000$10.5430,000(I)

View →

Jun 24, 2026Jun 26 8:19 PMRajeev DadooDirector
Grant/Award
30,000$10.5430,000(D)

View →

Jun 24, 2026Jun 26 8:15 PMPratik ShahDirector
Grant/Award
30,000$10.5430,000(D)

View →

Jun 24, 2026Jun 26 8:15 PMMichael KellyDirector
Grant/Award
30,000$10.5430,000(D)

View →

Jun 24, 2026Jun 26 8:15 PMSaqib IslamDirector
Grant/Award
30,000$10.5430,000(D)

View →

Jun 24, 2026Jun 26 8:15 PMPeter A. ThompsonDirector
Grant/Award
30,000$10.5430,000(D)

View →

Jun 24, 2026Jun 26 8:15 PMBrent L SaundersDirector
Grant/Award
30,000$10.5430,000(D)

View →

Jun 24, 2026Jun 26 8:15 PMPhillip M SchneiderDirector
Grant/Award
30,000$10.5430,000(D)

View →

Jun 24, 2026Jun 26 8:15 PMLaura ShawverDirector
Grant/Award
30,000$10.5430,000(D)

View →

Jun 12, 2026Jun 13 12:06 AMEric KarasChief Commercial Officer
Option Exercise
25,000$1.50519,588(D)

View →